A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

Clinical trial NCT07645287 · RECRUITING

Trial details

NCT number: NCT07645287
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2026-06-15
Primary completion: 2027-08-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.